Skip to main content
PACB
NASDAQ Industrial Applications And Services

PacBio Launches $100M At-The-Market Stock Program Via Allen & Company

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.249
Mkt Cap
$700.956M
52W Low
$1.07
52W High
$3.435
52W Position info
110% above low
Off High info
35% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PACB has more than doubled off its 52-week low of $1.07.

Summary

PacBio registered an at-the-market program to sell up to $100 million of common stock through Allen & Company, with no shares sold yet. Full use at the $2.36 reference price would add roughly 42.4 million shares to the 312.2 million outstanding.


Key Events · Financing and Capital Events · PACB

  • New $100M At-The-Market Program

    Sales agreement with Allen & Company LLC allows PacBio to offer and sell up to $100,000,000 of common stock from time to time at market prices; no shares have been sold under it yet.

  • Dilution If Fully Drawn

    Assuming 42,372,881 shares sold at $2.36 — the November 9 last reported sale price — the offering would add about 13.6% to the 312,236,834 shares outstanding as of September 30, 2026.

  • Agent Fees And Expenses

    Allen & Company receives up to 3% of gross proceeds, plus reimbursement of legal expenses up to $125,000 at signing and up to $25,000 per quarter; estimated offering expenses excluding agent compensation are about $512,500.

  • Balance Sheet Context

    Net tangible deficit was approximately $(395.8) million, or $(1.27) per share, at September 30, 2026; proceeds are earmarked for R&D and working capital.


Analysis · PACB · Industrial Applications And Services

PacBio is setting up a $100 million at-the-market program, giving it the ability to drip shares into the market at prevailing prices with no minimum and no obligation to sell. The timing matters: it lands six days after a $37.8 million quarterly loss and the same week the CFO announced his departure, so the program reads as runway insurance rather than opportunistic capital raising. At the $2.36 last reported sale price on November 9, full utilization would mean roughly 42.4 million new shares against 312.2 million outstanding — about 13.6% dilution — and the company already carries a $395.8 million net tangible deficit. Nothing has been sold yet; the size of the actual overhang depends entirely on how much management chooses to draw.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PACB was trading at $2.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $701M. The 52-week trading range was $1.07 to $3.44. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PACB - Latest Insights

PACB
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $2.31 info
Change: -$0.2312 (-9%) info
Market Cap: $700.956M info
PACB
Nov 04, 2026, 5:41 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $2.31 info
Change: -$0.2912 (-11%) info
Market Cap: $700.956M info
PACB
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $2.31 info
Change: -$0.3712 (-14%) info
Market Cap: $700.956M info
PACB
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.57
Real-time Price: $2.31 info
Change: -$0.2612 (-10%) info
Market Cap: $700.956M info
PACB
Aug 06, 2026, 5:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $2.31 info
Change: +$1.15 (+99%) info
Market Cap: $700.956M info